Wellington Management Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $37.4M | Buy |
|
|||||
2025
Q1 | $11M | Sell |
|
|||||
2024
Q4 | $106M | Sell |
|
|||||
2024
Q3 | $463M | Sell |
|
|||||
2024
Q2 | $1.12B | Sell |
|
|||||
2024
Q1 | $1.05B | Sell |
|
|||||
2023
Q4 | $968M | Sell |
|
|||||
2023
Q3 | $1.24B | Sell |
|
|||||
2023
Q2 | $1.2B | Sell |
|
|||||
2023
Q1 | $1.45B | Sell |
|
|||||
2022
Q4 | $1.74B | Sell |
|
|||||
2022
Q3 | $1.68B | Buy |
|
|||||
2022
Q2 | $1.41B | Sell |
|
|||||
2022
Q1 | $2.02B | Sell |
|
|||||
2021
Q4 | $1.98B | Sell |
|
|||||
2021
Q3 | $2.04B | Sell |
|
|||||
2021
Q2 | $2.27B | Buy |
|
|||||
2021
Q1 | $1.83B | Buy |
|
|||||
2020
Q4 | $1.75B | Buy |
|
|||||
2020
Q3 | $1.95B | Sell |
|
|||||
2020
Q2 | $2.28B | Buy |
|
|||||
2020
Q1 | $1B | Sell |
|
|||||
2019
Q4 | $845M | Buy |
|
|||||
2019
Q3 | $490M | Sell |
|
|||||
2019
Q2 | $557M | Sell |
|
|||||
2019
Q1 | $869M | Sell |
|
|||||
2018
Q4 | $1.12B | Sell |
|
|||||
2018
Q3 | $1.65B | Sell |
|
|||||
2018
Q2 | $1.51B | Buy |
|
|||||
2018
Q1 | $1.49B | Sell |
|
|||||
2017
Q4 | $1.63B | Sell |
|
|||||
2017
Q3 | $2.17B | Sell |
|
|||||
2017
Q2 | $2.72B | Sell |
|
|||||
2017
Q1 | $2.38B | Buy |
|
|||||
2016
Q4 | $2.09B | Sell |
|
|||||
2016
Q3 | $2.8B | Buy |
|
|||||
2016
Q2 | $2.2B | Buy |
|
|||||
2016
Q1 | $2.24B | Buy |
|
|||||
2015
Q4 | $2.6B | Sell |
|
|||||
2015
Q3 | $2.34B | Sell |
|
|||||
2015
Q2 | $2.81B | Sell |
|
|||||
2015
Q1 | $2.61B | Sell |
|
|||||
2014
Q4 | $2.41B | Buy |
|
|||||
2014
Q3 | $2.1B | Buy |
|
|||||
2014
Q2 | $1.6B | Buy |
|
|||||
2014
Q1 | $1.34B | Buy |
|
|||||
2013
Q4 | $1.19B | Buy |
|
|||||
2013
Q3 | $1.35B | Sell |
|
|||||
2013
Q2 | $1B | Buy |
|